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p63We have shown previously that during branching morphogenesis of the mouse prostate gland, Bone
morphogenetic protein 7 functions to restrict Notch1-positive progenitor cells to the tips of the prostate buds.
Here, we employed prostate-speciﬁc murine bi-genic systems to investigate the effects of gain and loss of
Notch function during prostate development. We show that Nkx3.1Cre and ProbasinCre alleles drive expression
of Cre recombinase to the prostate epithelium and periepithelial stroma. We investigated the effects of gain of
Notch function using the RosaNI1C conditional allele, which carries a constitutively active intracellular domain
of Notch1 receptor. We carried out the analysis of loss of Notch function in Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostates,
where RBP-J is a ubiquitous transcriptional mediator of Notch signaling. We found that gain of Notch function
resulted in inhibition of the tumor suppressor PTEN, and increase in cell proliferation and progenitor cells in
the basal epithelium and smooth muscle compartments. In turn, loss of Notch/RBP-J function resulted in
decreased cell proliferation and loss of epithelial and smooth muscle progenitors. Gain of Notch function
resulted in an early onset of benign prostate hyperplasia by three months of age. Loss of Notch function also
resulted in abnormal differentiation of the prostate epithelium and stroma. In particular, loss of Notch
signaling and increase in PTEN promoted a switch from myoblast to ﬁbroblast lineage, and a loss of smooth
muscle. In summary, we show that Notch signaling is necessary for terminal differentiation of the prostate
epithelium and smoothmuscle, and that during normal prostate development Notch/PTEN pathway functions
to maintain patterned progenitors in the epithelial and smooth muscle compartments. In addition, we found
that both positive and negative modulation of Notch signaling results in abnormal organization of the prostate
tissue, and can contribute to prostate disease in the adult organ.a).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The prostate is a sex-accessory exosecretory gland in mammalian
males. Prostate gland develops by branching morphogenesis from the
epithelium and mesenchyme of the urogenital sinus (UGS), an
enlarged portion of the urethra beneath the bladder. Adult prostate
is composed of branched ducts, made of stratiﬁed epithelium, sepa-
rated by the basal lamina from the ﬁbroblast stroma and smooth
muscle envelope. The luminal layer of prostate epithelium is char-
acterized by expression of speciﬁc intermediate ﬁlaments, cytokeratin
8 (CK8) andCK18, contains secretory cells, and is androgen-dependentfor cell survival and terminal differentiation (Marker et al., 2003; Wu
et al., 2007). In turn, cells in the basal epithelial layer are characterized
by expression of CK5 and CK14 (Marker et al., 2003). In addition, the
basal epithelium contains rare neuroendocrine cells, expressing neural
peptides, such as secretagogin, chromogranin, calcitonin gene-relater
peptide and synaptophasin (Abate-Shen and Shen, 2000;Marker et al.,
2003).
The prostate retains the ability to support cell replication, differ-
entiation and morphogenesis throughout adult life, which suggests
an abundance of pluripotent stem cells. Abnormal proliferation and
transformation of the prostate stem and progenitor cells results in
benign prostate hyperplasia and prostate cancers (Abate-Shen and
Shen, 2000; Marker et al., 2003). Recent studies indicate that prostate
gland contains at least two different stem cell niches, a “normal” stem
cell” niche in the basal compartment (Leong et al., 2008; Xin et al.,
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cells” in the luminal compartment (Wang et al., 2009). Notably,
regulation of cell fate choice in both normal and cancer prostate stem
cells is susceptible to the evolutionary conserved Notch cell fate
selection system (Artavanis-Tsakonas et al., 1999; Leong and Gao,
2008; Shahi et al., 2011; Yoon and Gaiano, 2005).
Recent studies by us and others underlined the importance of the
Notch1 receptor andNotch ligands, Delta-like1, Jagged1 and Jagged 2, in
prostate branching (Grishina et al., 2005; Wang et al., 2004) and
epithelial differentiation (Wang et al., 2006). Other studies indicated a
role for the Notch2 receptor and Delta-like1 ligand in survival and
differentiation of the prostate stroma (Orr et al., 2009). Activation of the
Notch receptor results in a γ-secretase dependent proteolytic cleavage
of the Notch intracellular domain (NIC) and its nuclear translocation
(Fig. 1). In the nucleus, NIC forms a transcription complexwith its DNA-
binding co-factor, RBP-J/Supressor of Hairless/Lag-1/CBF-1, and promotes
expression of the Hes/Hey/Herp transcriptional repressors (Artavanis-
Tsakonas et al., 1999; Belandia et al., 2005; Ohtsuka et al., 1999; Tanigaki
et al., 2002; Yoon and Gaiano, 2005). In the absence of Notch signaling,
RBP-J forms a complex with transcriptional repressors and prevents
opportunistic expression of theNotch target genes (Zhou andHayward,
2001). TheNotch targets, theHes/Hey/Herp factors, havebeen shown to
repress transcription of the proneural basic helix–loop–helix transcrip-
tion factors,Mash1,Math1 and Ngn3,which function to promote neural
differentiation in the neural tube and forebrain (Yoon and Gaiano,
2005), as well as secretory differentiation in the pancreas and intestine
(Fre et al., 2005; Murtaugh et al., 2003; Stanger et al., 2005; Yang et al.,
2001). Their role in neuroendocrinedifferentiation in the lungs has been
also suggested (Ito et al., 2000). Our studies and studies of other
laboratories indicate that during prostate development, Notch signaling
is mediated primarily by Hes1 and Hey1 (Belandia et al., 2005; Grishina
et al., 2005;Wang et al., 2004).Hey1 has been shown to function as a co-
repressor of the androgen receptor targets, indicating that inhibition of
Notch signaling may be required for differentiation of the prostate
secretory epithelium (Belandia et al., 2005; Wu et al., 2007).Fig. 1. The Notch pathway. Notch signaling between adjacent cells functions to diversify cel
terminally differentiate. In mammals, signaling by the Notch 1–4 transmembrane recep
transmembrane receptors on neighboring cells. Ligand–receptor binding promotes a seri
intracellular domain (NIC), then, by the ADAM metalloproteinase to remove the extracellula
factor together with its DNA-binding co-factor, RBP-J/Suppressor of Hairless/Lag-1/CBF-1. In
as a repressor for Notch target genes. NIC induces expression of the Hes/Hey/Herp family of
loop–helix (bHLH) transcription factors, Mash1, Math1 and Neurogenin. In the prostate, HeyImportantly, abnormal regulation of the Notch pathway has been
suggested to contribute to benign prostate tumors (Belandia et al.,
2005), andmay play a role in predisposition to prostate cancer (Whelan
et al., 2009). In particular, studies indicate that signaling by the Notch
receptor can affect proliferation and cell fate choice in prostate, and
other, cancer cell lines by regulating transcription of the phosphatase
and tensin homolog gene (PTEN) (Palomero et al., 2007; Salmena et al.,
2008;Whelan et al., 2009). PTEN is a lipid and protein phosphatase, and
a potent tumor suppressor which functions by antagonizing the
phosphoinositide 3-kinase (PI3K)/Akt cell survival pathway. Notably,
studies in cell lines pointed thatNotch can regulate PTENbothpositively
and negatively depending on cellular context (Palomero et al., 2007;
Salmena et al., 2008; Whelan et al., 2009). These ﬁndings make it
particularly important to deﬁne the interactions between theNotch and
PTEN/Akt pathways during normal prostate development, and during
the initial stages of benign and malignant prostate tumors.
In this study, we employed three prostate-speciﬁc Cre/LoxP systems
to investigate the effects of gain and loss of Notch signaling in mouse
models, during prostate formation in embryogenesis and during
postnatal differentiation of the organ. We used the prostate-speciﬁc,
Nkx3.1Cre and Probasin(PB)Cre4 drivers to express Cre recombinase in the
embryonic and postnatal prostate. Nkx3.1 is a prostate speciﬁc
homeobox gene which is expressed in the prostate epithelium from
the earliest stages of prostate budding at the embryonic (E) day E15.5
(Bhatia-Gaur et al., 1999). PBCre4 drives Cre expression in the prostate
epithelium and smooth muscle, postnatally, under a modiﬁed promoter
for a rat prostate secretory protein (Wu et al., 2001). To investigate the
effects of gain of Notch function, we used the conditional strain,
RosaNotch1IC (RosaN1IC) (Murtaughet al., 2003), carrying the constitutively
active intracellular domain of the Notch1 receptor, N1IC. To investigate
the effect of loss of Notch signaling, we used a ﬂoxed allele for the
ubiquitous transcriptionalmediatorofNotch signaling,RBP-Jﬂox (Tanigaki
et al., 2002). Our study uncovered intriguing similarities in Notch
function in the prostate epithelium and adjacent stroma. We found that
gain of Notch function during prostate development resulted inl fate: selecting progenitor cells which will maintain pluripotency, and cells which will
tors is activated by binding to the Delta-like1-4 and Jagged1,2 ligands, themselves
es of cleavages, ﬁrst, by the intracellular γ-secretase complex, to produce the Notch
r domain. Cleaved NIC translocates to the nucleus where it functions as a transcription
the absence of Notch signaling RBP-J remains bound to the consensus sites and functions
transcriptional repressors which in turn suppress transcription of the patterning basic-
1 functions as a co-factor for the androgen receptor (AR) to repress AR targets.
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increased proliferation of the basal and myoblast progenitors leading to
an early onset of benign prostate hyperplasia by three months of age. In
turn, loss ofNotch signaling resulted inupregulation of PTEN, loss of basal
and myoblast progenitors, and abnormal cell differentiation in both
epithelial and stromal compartments. Our studies point to the
importance of precise regulation of Notch signaling during prostate
development, and the role ofNotch in thehomeostasis of the adult organ.
Materials and methods
Mouse lines and X-gal staining
All mouse studies were conducted in accordance with an animal
protocol approved by the New York University School of Medicine
Institutional Animal Care and Use Committee. All mouse strains were
maintained in C3H/HeJ background (Taconic, NY) unless otherwise
indicated. Nkx3.1Cre strain is a gift fromM. Shen (Columbia University).
The Cre sequence is a knock-in resulting in a loss of Nkx3.1 function
(Wang et al., 2006). Genotyping for the Nkx3.1Cre allele was carried out
by PCR with a forward, Cre-F: GCG CGG TCT GGC AGT AAA AAC, and a
reverse Cre-R: CAG ATG GCG CGG CAA CAC C, primers, under the
following conditions: 94 °C, 5 min; 38 cycles of 94 °C for 15 s, 58 °C for
30 s, 72 °C for 1 min; then 72 °C for 10 min. PBCre4 is a transgenic strain
which drives expression of Cre-recombinase in the postnatal prostate
epithelium and in smooth muscle (Wu et al., 2001). Rosa26 is a Cre-
reporter strain which carries a LacZ gene preceded by stop codon
ﬂanked by LoxP sites (Soriano, 1999). RBP-Jﬂox (Tanigaki et al., 2002) is a
conditional loss of function allele of RBP-J, a ubiquitous transcriptional
mediator of canonical Notch signaling. RBP-Jﬂox strain is maintained as
homozygous in mixed SW/Bl6 background. RosaN1IC (Murtaugh et al.,
2003) is a conditional transgene, containing a sequence for the Notch1
intracellular domain,N1IC. Embryonic (E) day0.5 (E0.5)wasdesignated
as the day when vaginal plug was ﬁrst observed, and day of birth was
marked as postnatal (P) day 1 (P1). Sex of embryos, starting from E15.5,
wasdeterminedby the characteristic positions of the sexually committed
gonads. X-gal staining of the Nkx3.1Cre/+;Rosa26 and PBCre4/+;Rosa26
tissues has beenperformed as describedpreviously (Grishina et al., 2005;
Wu et al., 2009).
Tissue collection and immunoﬂuorescent analysis
Urogenital sinuses including prostate tissues were dissected from
male mice and embryos using Zeiss Stemi SV11 dissection microscope,
rinsed in ice cold PBS and ﬁxed in 4% paraformaldehyde for 1 h,
dehydrated and embedded in parafﬁn, and sectioned at 5 μm. For
immunoﬂuorescent labeling, sections were processed as described
previously (Grishina et al., 2005), and incubated with primary
antibodies overnight at 4 °C in the Tyromide Signal Ampliﬁcation
(TSA, Invitrogen, Carlsbad, CA) or Mouse On Mouse (Vector Laborato-
ries, Burlingame, CA) blocking solutions, followed by incubation with
Alexa Fluor secondary antibodies (Invitrogen, Carlsbad, CA), or
processed with the TSA kit #23 kit (Invitrogen, Carlsbad, CA) according
to manufacturer's instructions. Primary antibodies for Ki-67 (catalogue
number 15580, Abcam, Cambridge, MA) and phospho-Histone H3
(pHH3) (catalogue number 6570, Upstate Biotechnology, Billerica, MA)
were used at 1:100 dilution, and antibodies for smooth muscle α-actin
(α-sma) (Clone 1A4, DAKO, Glostrup, Denmark) and myosin (BT-562,
BTI, Stoughton,MA)wereusedat 1:100dilution, followedbyAlexaFluor
secondary antibodies. Primary antibodies for PTEN (catalogue number
9559, Cell Signaling, Danvers, MA) and N1IC (catalogue number 2421,
Cell Signaling, Danvers,MA)were used at 1:100dilution, and antibodies
for CK8 (catalogue number 14053, Abcam, Cambridge, MA), CK14
(catalogue number PRB-155P, Covance, Princeton, NJ), Bcl-2 (catalogue
number 18210, Abcam, Cambridge, MA), p63 (catalogue number 3239,
Abcam, Cambridge, MA), and phospho-Akt (pAkt) (catalogue number4060, Cell Signaling, Danvers, MA) were used at 1:50 dilution with the
Tyromide Signal Ampliﬁcation kit # 23 (Invitrogen, Carlsbad, CA) as
described (Grishina et al., 2005). Fluorescent imaging was performed
using Zeiss Axioplan3.1 ﬂuorescentmicroscope at the Urology Research
Laboratories, and the LSW 510 confocal scope at the New York
University School of Medicine Microscopy Core Facility.
Analysis of programmed cell death
Programmed cell deathwas evaluated on tissue sections by terminal
deoxynucleotidyl transferase dUTP nick end labeling reaction (TUNEL)
following the manufacturer's instructions (Roche Applied Science,
Indianapolis, IN).
Quantitations and statistics
In embryonic tissues, calculations of the percentage ratios for the
cells positive for TUNEL and immunohistochemical markers were
carried out in comparison to the total cell number in the particular
epithelial or stromal compartment identiﬁed by 4′,6-diamidino-2-
phenylindole (DAPI) staining of the nuclei. Cell countswere performed
on twenty tissue sections, ﬁve each from ﬁve non-littermate embryos
of each genotype, unless otherwise indicated. In the postnatal prostate,
cell counts for speciﬁc markers were carried out in ﬁve 106 μm2
quadrants on each of twenty sections from ﬁve non-littermate animals
of each genotype, unless otherwise indicated. Measurements and cell
counts were performed using Axiovision 2 (Carl Zeiss MicroImaging,
Thornwood, NY) and Volocity 5.3.1 Software (Perkin Elmer, Waltham,
MA). Statistical signiﬁcance of the calculations was determined by the
Student's t-test. Pb0.05 was considered signiﬁcant.
Results
Nkx3.1Cre is expressed in epithelial and mesenchymal prostate cells
Nkx3.1 is a prostate-speciﬁc homeobox gene and tumor-suppressor
(Bhatia-Gaur et al., 1999; Kim et al., 2002; Abate-Shen et al., 2003). In
embryogenesis, transient Nkx3.1 expression has been also reported in
the lungs, somites, duodenum and elements of the skeleton (Stanfel et
al., 2006). First, we determined the domains of Cre recombinase
expression in our Nkx3.1Cre strain (gift of M. Shen, Columbia).
Nkx3.1Cre/+ males were mated with the Rosa26 females (Soriano,
1999), and the resulting Nkx3.1Cre/+;Rosa26 embryos and postnatal
prostateswere analyzed for expression of the LacZ reporter (Fig. 2). LacZ
expression was ﬁrst detected in the UGS epithelium at E16.5 (Fig. 2F,
arrow), and at E17.5, in the emerging buds of the prostate (Figs. 2B and
H) and bulbourethral glands (Fig. 2B). In embryogenesis, LacZ
expression was also present in a few cells in the periepithelial
mesenchyme in between the urethra and smooth muscle (* in
Figs. 2F–H, and in Supplemental Material Figs. S1A, B). At the postnatal
stages, LacZ was expressed in all prostate lobes (Figs. 2C–E), in the
luminal and basal epithelial layers (Figs. 1I–N), and also in the smooth
muscle compartment (* in Figs. 2J, L, and N and Supplemental Material
Figs. S1C–F). This shows that theNkx3.1Cre allele drives expressionof Cre
recombinase in the prostate epithelium and periepithelialmesenchyme
starting from the earliest stages of prostate development (Figs. 2B, F–H).
Thus, Nkx3.1Cre is suitable to manipulate gene function in the prostate
epithelium and adjacent stroma.
In this study, we employed the Nkx3.1Cre driver to analyze the
effects of gain and loss of Notch function during embryonic prostate
development using theNkx3.1Cre/+;RosaN1IC/+ (Fig. 3) andNkx3.1Cre/+;
RBP-Jﬂox/ﬂox systems (Figs. 6–10). We also found that Nkx3.1Cre/+;
Rosa26 embryos show LacZ expression in the axial mesoderm
(Figs. 2O–Q, and S), similar as described for an independently made
Nkx3.1Cre strain (Stanfel et al., 2006). This is consistent with a transient
expression of Nkx3.1 in the developing somites (Kos et al., 1998). In our
Fig. 2. LacZ expression in theNkx3.1Cre/+; Rosa26 prostates and embryonic axial mesoderm. (A) Schematic representation of themale urogenital system at P3: bl, bladder; ur, urethra;
sv, seminal vesicles; bg, bulbourethral gland; ap, anterior prostate; dp, dorsal prostate lobes; lp, lateral prostate lobes; vp, ventral prostate. (B–N) Nkx3.1Cre;Rosa26 UGS and prostate
tissues were stained with X-gal (B–E), sectioned (F–N), and immunolabeled with α-sma (G, J, L, N). Analysis in whole mount at E17.5, P3, P15 and P28 showed LacZ expression in all
prostate lobes (C–E) and in the bulbourethral gland (B–C). (F–H, dorsal side is up) In embryogenesis, at E16.5 and E17.5, LacZ expression was detected in the UGS epithelium (arrow
in F), in the prostate buds (arrow in H), and in the mesenchyme in between the UGS epithelium and smooth muscle (* in F and H; and in Supplemental Material Figs. S1A, B). (I–N)
Sections of Nkx3.1Cre;Rosa26 prostates at P3 (I, J), P15 (K, L) and P28 (M, N) show LacZ expression in the basal and luminal prostate epithelium, and also in the periductal smooth
muscle (* in J, L, N, and in Supplemental Material Figs. S1C–D). (O–Q, and S) Analysis ofNkx3.1Cre/+;Rosa26 embryos at E13.5 and E14.5, also showed activity of theNkx3.1 promoter in
the axial mesoderm. Nkx3.1Cre/+;Rosa26 embryos were stained with X-gal in whole mount (O–Q), and sectioned (S) at a position indicated with dashed line in (O). (R) Dorsal view of
a Nkx3.1Cre/+;RosaN1IC/+ (N1IC/+) embryo at E14.5 showing incomplete closure of the neural tube (arrow). Scale bars: 50 μm.
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the Nkx3.1Cre/+;RosaN1IC/+ embryos resulted in lethality at birth due to
incomplete closure of the neural tube (Fig. 2R). Thus, to analyze the
effect of gain of Notch function in the postnatal prostate (Figs. 4–5), we
employed the PBCre4 strain,which has been reported to drive expression
of Cre in the prostate epithelium and smooth muscle, postnatally (Wu
et al., 2001). PBCre4/+;RosaN1IC/+ andNkx3.1Cre/+;RBP-Jﬂox/ﬂoxmaleswere
viable, fertile, and showed no gross morphological defects which
allowed us to analyze the effects of gain (Figs. 4–5) and loss of Notch
function (Figs. 6–10) in the postnatal and adult prostates.
Gain of Notch function in embryonic prostates results in increased cell
proliferation and survival
To determine the effect of gain of Notch function during the initial
stages of prostate formation and outgrowth of the primary buds, UGS
sections were obtained from Nkx3.1Cre/+;RosaN1IC/+ male embryos at
E17.5 (Figs. 3A–L) and E18.5 (Figs. 3M–V). To determine the sites of
endogenous and transgenic Notch1 activity in the developing prostate,
weused antibodies to the intracellular domainofNotch1 (N1IC) cleaved
at Valine 1744 (#2421, Cell Signaling, Danvers, MA) which only detect
the activated form of Notch1 receptor indicative of Notch signaling. In
wild-type E17.5 (Fig. 3A) and E18.5 UGS (Fig. 3N), endogenous Notch1
activity was detected in the UGS epithelium, in the forming prostate
buds (Figs. 3A and N), and in a few cells in the urogenital mesenchyme
(arrows in insets in Figs. 3A andN). Our previous studies (Grishina et al.,
2005) also showed endogenous Notch1 activity, and expression ofHes1,in the embryonic UGS epitheliumandmesenchyme. In turn,Nkx3.1Cre/+;
RosaN1IC/+ embryos showed signiﬁcantly higher levels ofN1IC in theUGS
epithelium, emerging prostate buds, and in the mesenchyme (Figs. 3G
compare to A, and S compare to N). This robust increase in the N1IC
protein in the Nkx3.1Cre/+;RosaN1IC/+ prostates is a further conﬁrmation
that Nkx3.1Cre efﬁciently drives expression of Cre-recombinase, and the
N1IC transgene, in the UGS and prostate epithelium, and in some cell
populations in the mesenchyme.
We further examined E17.5 Nkx3.1Cre/+;RosaN1IC/+ prostates for
cell proliferation and survival by immunolabeling for Ki-67 (Figs. 3B
and H), phospho-histone H3 (pHH3) (Figs. 3C and I), and carrying out
a TUNEL assay (Figs. 3D and J). Calculations of percentage ratios for
cells positive for Ki-67, pHH3 and TUNEL, were carried out in compar-
ison to the total number of cells, identiﬁed by the DAPI staining of the
nuclei in the embryonic UGS, or in the mesenchyme within 25 μm of
the epithelium using Volocity 5.3.1 Software. We found that E17.5
Nkx3.1Cre/+;RosaN1IC/+ UGS epithelium contained approximately 17%
more Ki-67+ cells (Pb0.01) (Figs. 2X, and B, H), and 9% (Pb0.01) more
pHH3+ mitotic cells (Figs. 3W, and C, I) than the control tissues. In
addition, we found a 10% increase in mitotic cells (Pb0.01) in the
Nkx3.1Cre/+;RosaN1IC/+ periepithelial mesenchyme (Figs. 3W, and C, I).
Quantitation of the TUNEL+epithelial cells in the Nkx3.1Cre/+;RosaN1IC/+
and control UGS epithelium (Figs. 3W and D, J) showed only a modest
4% (Pb0.02) decrease in programmed cell death. These results show
that gain of Notch function in the embryonic prostates results in a
10% increase in cell proliferation in the epithelial and mesenchymal
compartments.
Fig. 3. Gain of Notch function in embryogenesis causes downregulation of PTEN, and increase in cell proliferation and basal progenitors. (A–V) Nkx3.1Cre/+;RosaN1IC/+ (N1IC/+) and
control, Nkx3.1+/+;RosaN1IC/+, prostate sections at E17.5 (A–L) and E18.5 (M–V) were stained with hematoxylin and eosin (M, R), and labeled for N1IC (A, G, N, S), Ki-67 (B, H), pHH3
(C, I), pAkt (E, K), p63 (F, L), PTEN (O, T); CK14 (P, U), and Bcl-2 (Q, V). Scale bars, 100 μm. (A, G, N, S) Insets in (A) and (N) show high magniﬁcation images of the UGS mesenchyme
in the framed areas. Arrows indicate N1IC-positive cells in the mesenchyme. (X) Graphs show percentage ratios of cells in the wild-type (dark bar) and N1IC/+ (light bar) UGS
epithelium at E17.5 positive for Ki-67, TUNEL assay. Percentage ratio of cells in epithelium (ep) and periepithelial mesenchyme (pm) positive for pHH3. Number of p63+ cells per
104μm2. For each experiment, positive cells were counted on twenty UGS sections ﬁve sections from four non-littermate embryos of each genotype using Volocity 5.3.1 software.
Student's t-test; horizontal bars, standard mean; horizontal lines, standard errors; *Pb0.05; **Pb0.01.
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of PTEN, and increase in phosphorylation of Akt
PTEN is a lipid and protein phosphatase, which functions as a tumor
suppressor by antagonizing the PI3K/Akt cell survival pathway and
inhibiting the cell divisions cycle (Salmena et al., 2008). Thus, we asked
whether Notch signaling functions to favor cell survival and prolifera-
tion by limiting levels of PTEN. We detected signiﬁcant levels of PTEN
protein in the normal E18.5 UGS epithelium and adjacent mesenchyme
(Fig. 3O). In contrast, in E18.5 Nkx3.1Cre/+;RosaN1IC/+UGS, PTEN protein
was absent in the epithelium, an only present in a few cells in the
mesenchyme (Figs. 3T compare to O). Nkx3.1Cre/+;RosaN1IC/+ UGS, ana-
lyzed at E17.5 and E18.5, also showed higher levels of phospho-Akt in
the epithelium and mesenchyme (Figs. 3K compare to E, and data notshown), and an increase in the phospho-Akt target, the cell survival
factor, Bcl-2 (Figs. 3Q andV). These results show that induction of Notch
signaling in the embryonic UGS results in downregulation of PTEN and
upregulation of the Akt/Bcl2 survival pathway.
Gain of Notch function results in increased number of p63+ progenitors
in the embryonic prostate
Several studies indicate that transcription factor p63 marks a basal
prostate cell population enriched for stem and progenitor cells (Shahi
et al., 2011; Signoretti et al., 2005;Xin et al., 2007).We found that gain of
Notch function in embryonic prostate resulted in higher rates of cell
divisions in the basal UGS epithelium (Figs. 3H and B, and I and C). Thus,
we asked whether this increase in cell proliferation would speciﬁcally
Fig. 4. Gain of Notch function results in overproliferation of basal epithelium and myoblasts in P7–P14 prostates. (A) P14 ventral PBCre4/+;Rosa26 prostate stained with X-gal and
immunolabeled for α-sma shown in bright light (upper panel), and with ﬂuorescent and bright light (lower panel). LacZ expression is detected in the prostate epithelium and
periductal smooth muscle. (B, H) Sections of P14 control, PB+/+;RosaN1IC/+, (B) and PBCre4/+;RosaN1IC/+ (H) ventral prostate lobes, labeled for N1IC. (H) N1IC is upregulated in the
PBCre4/+;RosaN1IC/+ prostate epithelium (arrowhead) and smooth muscle (arrow). (C, I) Sections of P7 wild-type (C) and PBCre4/+;RosaN1IC/+ (I) ventral prostates, labeled for p63,
show increase in p63+ cells in the N1IC/+ basal epithelium. (D, J) Sections of P14 control (D) and PBCre4/+;RosaN1IC/+ (J) ventral prostates, labeled for CK14, show increase in CK14+
cells. (E, K) Sections of P14 control (E) and PBCre4/+;RosaN1IC/+ (K) ventral prostates, labeled for Ki-67. (F–G, L–M) Sections of P14 control (F–G) and PBCre4/+;RosaN1IC/+ (L–M) ventral
prostates, labeled for α-sma. (G) and (M) show higher resolution images of the framed areas in (F) and (L), respectively. Scale bars, 25 μm. (N) Percentage ratios of p63+ cells in
control (dark bar) and PBCre4/+;RosaN1IC/+ (light bar) ventral prostate ducts, counted at P7. Percentage ratios of CK14+ cells in PBCre4/+;RosaN1IC/+ and control ventral prostates ducts,
counted at P14. Percentage ratios of Ki-67+ cells calculated in the epithelium (ep) and periepithelial mesenchyme (pm). The number (N, sml) and thickness (μm, sml) of periductal
smooth muscle layers measured in the control andmutant prostates. Cell counting andmeasurements were carried out on 20 transverse prostate sections, 4 each from 5 prostates of
each genotype. Student's t-test: *Pb0.05, **Pb0.01.
342 X. Wu et al. / Developmental Biology 356 (2011) 337–349affect the basal progenitor cells. Indeed, Nkx3.1Cre/+;RosaN1IC/+ E17.5
UGS showed a substantial 52% increase in thenumber of p63+epithelial
progenitors (Pb0.01) compare to wild-type tissue (Figs. 3W, and LFig. 5. Hyperplastic epithelium and stroma in three month old PBCre4/+;RosaN1IC/+ ventral
prostates were stained with hematoxylin and eosin (A, G and a high magniﬁcation inset) an
(E, H) andmyosin (F, L). (A) Control prostates show normal tissue histology and accumulatio
secretory function, contain detached epithelial aggregates in the lumen (arrowhead), and sh
ducts show increased number of CK14+ basal cells (H compare to B); a hyperplastic lumin
envelopes (E, K and F, L). Scale bars: 50 μm.and F). This coincided with increased expression of the basal CK14 in
E18.5 Nkx3.1Cre/+;RosaN1IC/+ UGS (Figs. 3U and P), and a prominent
epithelial stratiﬁcation.prostates. Sections of 3 month old PBCre4/+;RosaN1IC/+ (G–L) and control (A–F) ventral
d immunolabeled for CK14 (B, H), CK8 (C, I), AR (D, J), and smooth muscle (sm) α-actin
n of prostate secretions in the lumen (A, *). (G) PBCre4/+;RosaN1IC/+ ventral prostates lack
ow ﬁbro-muscular nodules within prostate stroma (arrow). PBCre4/+;RosaN1IC/+ prostate
al epithelium (G and inset, I and J, compare to A, C and D); and thicker smooth muscle
Fig. 6. Loss of RBP-J results in decreased cell proliferation and survival in the embryonic and P1 UGS. (A–C, E–F) Nkx3.1Cre/+;RBP-Jﬂox/ﬂox and control, Nkx3.1+/+;RBP-Jﬂox/ﬂox, UGS
sections at E17.5 and P1 were labeled for Ki-67 (A and E, and B and F), and processed for TUNEL assay (C, G). Scale bars: 100 μm. (D) Percentage ratios for Ki-67+ (D) cells were
calculated separately in the UGS epithelium (ep) and periepithelial mesenchyme (pm), on sixteen sections, four each from four embryos of mutant and control genotype, at E17.5
and P1. (H) TUNEL+ cells in the UGS epithelium were calculated same as described above. Student's t-test; horizontal bars, standard mean; horizontal lines, standard errors;
*Pb0.05; **Pb0.01.
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the postnatal prostate
Previous analysis of the PBCre4/+;Rosa26 reporter system (Wu et al.,
2001) showed LacZ expression in all prostate lobes fromP1 to 8 weeks of
age.Wuet al. (2001) also performedhistological analysis of X-gal stained
prostate sections to showCreexpression in theperiductal smoothmuscle
(Wu et al., 2001). Our analysis of sections of P14 PBCre4/+;Rosa26 ventral
prostates, X-gal stained and immunolabeled for α-sma, conﬁrmed LacZ
expression in the prostate epithelium and in adjacent smooth muscle
(Fig. 4A). Further examinationof thePBCre4/+;RosaN1IC/+ventral prostates
showed a signiﬁcant increase in the N1IC signal in the ductal epithelium
(Figs. 4H and B), prostate buds (arrowhead in Fig. 4H), and smooth
muscle (arrows in Fig. 4H, and in SupplementalMaterial Figs. S1E and F).
We further examined whether gain of Notch function affected cell fate
choice in the epithelium or stroma. We ﬁrst examined whether gain of
Notch function in postnatal prostates resulted in increased cell
proliferation. We labeled twenty prostate sections from P14 PBCre4/+;
RosaN1IC/+ and control, PB+/+;RosaN1IC/+ prostates, for Ki-67, and
counted the number of Ki-67+ cells in ﬁve 106 μm2 quadrants on eachFig. 7. Loss of RBP-J results in defects in organization of the UGS epithelium. (A–H) Nkx3.1C
hematoxylin (A, E, and higher magniﬁcation images of the framed areas in B and F), and imm
H). (E–H) Nkx3.1Cre/+;RBP-Jﬂox/ﬂox UGS showed simple cuboidal epithelium (H), and delamisection in the ventral (Figs. 4E, K and N), anterior, dorsal and lateral
prostate lobes (not shown).We found a 22% (Pb0.01) increase in Ki-67+
cell in the epithelium of P14 PBCre4/+;RosaN1IC/+ ventral prostates, and
approximately 10% (Pb0.05) increase in the proximal mesenchyme
(Fig. 4N). Similar increase in the rates of cell proliferationwasobserved in
the anterior, dorsal and lateral lobes (data not shown).
Gain of Notch function results in increase in the basal and smooth
muscle progenitor cells in the postnatal prostate
Todeterminewhether gain ofNotch activity in thepostnatal prostate
affects the p63+ cell population we performed immunolabeling of
prostate sections from P7 PBCre4/+;RosaN1IC/+ and control, PB+/+;
RosaN1IC/+males (Figs. 4C and I, ventral lobe is shown). We found a
7.6% (Pb0.01) increase in the p63+ population within the ventral
prostate lobes (Figs. 4N, and C, I). PBCre4/+;RosaN1IC/+ ventral prostates
also showed a 12% (Pb0.01) increase in CK14+ basal cells at P14
(Figs. 4N, and D, J). The anterior, lateral and dorsal PBCre4/+;RosaN1IC/+
prostate lobes showed a similar increase in p63+ and CK14+ cells (data
not shown). Interestingly, we found that P14 PBCre4/+;RosaN1IC/+ ventralre/+;RBP-Jﬂox/ﬂox and control littermate UGS sections at P1 were stained with eosin and
unolabeled for CK14 (C, G, and higher magniﬁcation images of the framed areas in D and
nation of cells into the lumen (arrowheads). Scale bars: 100 μm.
Fig. 8. Loss of RBP-J results in increased levels of PTEN, and loss of basal and smooth muscle cells in postnatal prostates. (A–E) Immunolabeling shows a reduction of p63-positive
basal epithelium in Nkx3.1Cre/+;RBP-Jﬂox/ﬂox ventral prostates (B and D) compare to the control Nkx3.1+/+;RBP-Jﬂox/ﬂox littermates at P1 (A) and P7 (C). (E) Percentage ratios of p63+
cells in the control (dark bar) and Nkx3.1Cre/+;RBP-Jﬂox/ﬂox (light bar) prostate epithelium at P1 and P7. Student's t-test; horizontal bars, standard mean; horizontal lines, standard
errors; **Pb0.01. (F–H) Immunolabeling of control (F) and Nkx3.1Cre/+;RBP-Jﬂox/ﬂox (G) sections at P14 shows increased levels of PTEN in Nkx3.Cre/+;RBP-Jﬂox/ﬂox epithelial ducts and
periductal stroma. (H) Percentage ratios of PTEN+ cells in P14 wild-type (dark bar) and Nkx3.1+/+;RBP-Jﬂox/ﬂox (light bar) prostate epithelium (ep) and periductal stroma (st). (I, J)
Labeling for α-sma shows a reduced number of myoblasts surrounding distal Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostate ducts (J) compared to the control littermate tissue (G). Scale bars:
25 μm.
344 X. Wu et al. / Developmental Biology 356 (2011) 337–349ducts were surrounded by an abnormally thick layer of smooth muscle
(Figs. 4L andM, compare to F andG).Wild-type P14ventral ducts have a
1.6–2.0 layers of smooth muscle (Fig. 4N). In contrast, P14 PBCre4/+;
RosaN1IC/+ ducts had 2.9–3.1 (Pb0.01) layers of smooth muscle cells
(Fig. 4N).Moreover, PBCre4/+;RosaN1IC/+ smoothmuscle envelopes were
on average 60% thicker than in the control prostates (Figs. 4N, and G
compare to M). Measurements conducted using Axioplan 2 (Carl Zeiss
MicroImaging) software showed that control P14 ventral ducts were
surrounded by 3.0–4.5 μm of smooth muscle (Figs. 4N, and F, G). In
contrast, PBCre4/+;RosaN1IC/+ smoothmuscle envelopeswere 5.5–6.7 μm
thick (Pb0.01) in the ventral lobe (Figs. 4N, and L, M). The anterior,
lateral anddorsal lobes showed a similar increase in smoothmusclemass
(not shown). Furthermore, high resolution imaging of α-actin ﬁlaments
andchromatin labelingwithDAPI showed that at P14,PBCre4/+;RosaN1IC/+
smooth muscle layer contained cells with rounded morphology and
nuclei shape (Fig. 4M), suggesting that these cells are immature
myoblasts. In contrast, wild-type prostate ducts were surrounded by
tightly packed myocytes with condensed elongated nuclei (Figs. 4G andF). PBCre4/+;RosaN1IC/+ myoblasts also showed a looser arrangement of
the actin ﬁlaments (Fig. 4M) compared to the tightly packed actin
bundles in wild-type smooth muscle (Fig. 4G). Thus, gain of Notch
function resulted in a delay in myoblasts to myocyte differentiation. In
summary, our studies show that gain of Notch function in the postnatal
prostate results in increase in progenitor cells in the basal and smooth
muscle compartments.
Gain of Notch function results in an early onset of prostate hyperplasia
Wenext askedwhether gain of Notch activity in postnatal prostates
may lead to pathological conditions, such as benign hyperplasia or
intraepithelial neoplasia, in the adult. To examine the effect of gain
of Notch function on cell differentiation and tissue integrity in the
adult gland, we obtained prostate tissues from six three month old
PBCre4/+;RosaN1IC/+ and control males, and analyzed tissue histology
and differentiation of the epitheliumand smoothmuscle in all prostate
lobes (Fig. 5, ventral prostate is shown). Control prostates showed
Fig. 9. High levels of PTEN are present in vimentin+ ﬁbroblasts and myoﬁbroblasts. Adjacent sections of the proximal regions of the dorsal Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostate at P10
were double-labeled for PTEN and α-sma (A, C, E), or PTEN and vimentin (vmn) (B, D, F). (C–F) High resolution images of the framed areas in (A) and (B). Sections were imaged on
Axioplan2 (Zeiss) ﬂuorescent microscope (A–D) and LSW510 confocal scope (E–F). PTEN+vmn+α-sma− ﬁbroblasts are indicated with arrows. PTEN+vmn+α-sma+myoﬁbroblasts
are indicated with *. Scale bars: 100 μm.
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(Fig. 5A, *). In contrast, ventral and lateral PBCre4/+;RosaN1IC/+ ducts
lacked prostate secretions (Fig. 5G, and data not shown), and showed
extensive hyperplasia in the epithelial and stromal compartments
(Figs. 5G–L compare to A–F) in all mutant animals studied (6:0).
Immunolabeling for CK14, showed hyperproliferation of the basal
epithelium in PBCre4/+;RosaN1IC/+ prostates (Figs. 5H compare to B).
Examination of histological sections (Figs. 5A, G and inset) and
immunolabeling for the luminal markers, CK8 (Figs. 5C and I) and
androgen receptor (Figs. 5D and J), revealed that PBCre4/+;RosaN1IC/+
prostates also developed hyperplastic luminal epithelium whichFig. 10. Conditional RBP-J null prostates show distended ductal lumens, and thin
epithelium and smooth muscle at P28. Histological analysis of P28 control (A) and
Nkx3.1Cre/+;RBP-Jﬂox/ﬂox (B) prostate sections shows larger ductal lumens in the mutant
ventral (VP) and lateral (LP) prostate ducts. P28 Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostate ducts
(B) have thinner ductal epithelium (arrows) and smooth muscle envelopes (arrow-
heads), and lower stromal content (*) than control tissues (A). Transverse P28 UGS
sections were stainedwith eosin and hematoxylin. Dorsal side is up. Scale bars: 100 μm.folded into internal crypts (Figs. 5G and inset, I–J).Wenotednumerous
cell aggregation and occasional bridging in the PBCre4/+;RosaN1IC/+
luminal crypts (Figs. 5G and inset, I and J), and detached epithelial
aggregates in the lumen (Fig. 5G, arrowhead). PBCre4/+;RosaN1IC/+
luminal compartment showednormal levels of CK8 (Figs. 5C and I) and
androgen receptor (Figs. 5J compare to D). Thus, gain of Notch function
resulted in overproliferation of the basal and luminal prostate
epithelium. Gain of Notch function did not affect speciﬁcation of the
luminal epithelium, but inhibited secretory differentiation in the
ventral and lateral prostate lobes. Next, we examined the effect of gain
of Notch function on the organization and differentiation of the
stromal compartment in the adult prostate. Sections of three month
old PBCre4/+;RosaN1IC/+ and control prostates were analyzed for
histology (Figs. 5A and G), and by immunolabeling for the myoblast
marker, α-sma (Figs. 5K compare to E), and smooth muscle myosin
(Figs. 5L compare to F), which is expressed in mature myocytes. Three
month old PBCre4/+;RosaN1IC/+ prostates showed thick smooth muscle
envelopes with excess ofα-sma+myoblasts (Figs. 5K and E). PBCre4/+;
RosaN1IC/+ prostates also contained numerous ﬁbro-muscular nodules
in the stroma (Fig. 5G, arrow). These stromal conditions are also typical
for benign prostate hyperplasia in men. PBCre4/+;RosaN1IC/+ ventral
(Fig. 5) and lateral prostate lobes (not shown) showed essentially
identical characteristics of benign prostate hyperplasia in the
organization of the epithelial and stromal compartments. The anterior
and dorsal lobes showed similar levels of excess basal and myoblast
cell proliferation, but less extensive cell proliferation in the luminal
compartment, and retained secretory activity (not shown). In sum-
mary, our results show that gain of Notch function in postnatal
prostates resulted in an early onset of benign prostate hyperplasia by
Fig. 11. Conditional RBP-J null prostates at P21 show abnormal basal epithelium and loss of smooth muscle. Sections of P21 control (A–D) and Nkx3.1Cre/+;RBP-Jﬂox/ﬂox anterior
prostates (E–H) were labeled for CK8 (A, C and E, G), CK14 (B, C and F, G) and α-sma (D, H). Scale bars, 12 μm.
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basal, luminal and smooth muscle lineages in the PBCre4/+;RosaN1IC/+
model, consistent with human disease.Loss of Notch/RBP-J function results in decreased cell proliferation and
survival
To investigate the effect of loss of Notch signaling during prostate
development, we employed the Nkx3.1Cre/+;RBP-Jﬂox/ﬂox bigenic
system, where the ubiquitous transcriptional mediator of Notch,
RBP-J , is inactivated in the epithelial and mesenchymal prostate
cells where Nkx3.1 is expressed (Fig. 2 and Supplemental Material
Fig. S1). Nkx3.1Cre/+;RBP-Jﬂox/ﬂox males showed no apparent mor-
phological abnormalities, developed to adulthood, and were fertile.
Thus, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox mice and embryos for this study were
obtained bymatingNkx3.1Cre/+;RBP-Jﬂox/ﬂoxmales to RBP-Jﬂox/ﬂox females,
and progeny were genotyped for the Nkx3.1Cre allele by PCR. We ﬁrst
determined whether loss of RBP-J resulted in altered cell proliferation
at the early stages of prostate development, at E17.5 and P1 (Figs. 6A–B,
D–F). UGS sections from E17.5 (Figs. 6A and E) and P1 (Figs. 6B and F)
Nkx3.1Cre/+;RBP-Jﬂox/ﬂox and control, Nkx3.1+/+;RBP-Jﬂox/ﬂox, littermates
were labeled for Ki-67, andKi-67+ cells quantiﬁed separately in theUGS
epithelium (Fig. 6D, ep) and within 25 μm of the periepithelial
mesenchyme (Fig. 6D, pm). We found that loss of Notch/RBP-J function
resulted in lower levels of cell proliferation in embryonic and P1 UGS
epithelium and mesenchyme (Figs. 6D, and A compare to E, and B
compare to F). At E17.5,Nkx3.1Cre/+;RBP-Jﬂox/ﬂoxUGS epithelium showed
14.6% (Pb0.01) fewer cycling cells thancontrol tissue (Figs. 6D, andA, E).
At P1, 15.6% (Pb0.01) fewer dividing cells were found in the mutant
prostate tips compared to controls (Figs. 6D, and B, F). In theNkx3.1Cre/+;
RBP-Jﬂox/ﬂox periepithelial mesenchyme, cell proliferation was 6.5%
(Pb0.01) lower at E17.5 (Figs. 6D, and A, E), and 6.2% (Pb0.05) lower
at P1 (Figs. 6D, and B, F). We then determined whether loss of RBP-J
resulted in altered cell survival by carrying out TUNEL analysis at
P1 (Figs. 6C, G, and H). We found that loss of Notch/RBP-J function
resulted in a signiﬁcant decrease in cell survival in the UGS epithelium.
Speciﬁcally, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox P1 prostates contained 30%
(Pb0.01) more apoptotic nuclei in the UGS epithelium than control
tissues (Figs. 6H, and C, G).Loss of RBP-J resulted in defects in stratiﬁcation in the UGS epithelium
Histological analysis of prostate sections at P1 showed no
signiﬁcant difference in the number of the initial prostate buds in
theNkx3.1Cre/+;RBP-Jﬂox/ﬂox and control prostates (Figs. 7A, C and E, G).
Thus, Notch/RBP-J function is not required for speciﬁcation of the
prostate lobes. However, we found severe defects in organization of
the Nkx3.1Cre/+;RBP-Jﬂox/ﬂox UGS epithelium (Fig. 7). Normally, at the
embryonic and early postnatal stages, urethral epithelium is multi-
layered and pseudostratiﬁed (Marker et al., 2003). This was conﬁrmed
by histological analysis (Figs. 7A–B), and labeling of the wild-type P1
UGS for CK14 (Figs. 7C and D). In contrast, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox
UGS epithelium consisted of a single layer of cuboidally shaped cells
(Fig. 7H). Nkx3.1Cre/+;RBP-Jﬂox/ﬂox UGS epithelium also showed
signiﬁcant sheddingof cells into the lumen (Figs. 7E and F arrowheads)
consistentwith increased levels of cell death (Figs. 6G andH). This data
indicates that loss of Notch/RBP-J function resulted in signiﬁcant
defects in differentiation and organization of the UGS epithelium.
Loss of Notch/RBP-J function results in increased levels of PTEN, and
defects in maintenance of the basal and myoblast progenitors
We further determinedwhether loss of RBP-J affectedmaintenance of
epithelial and smooth muscle progenitors in the postnatal prostate.
Immunolabeling for p63 showed that Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostates
rapidly loose p63+ basal cells postnatally (Figs. 8A–E). At P1,Nkx3.1Cre/+;
RBP-Jﬂox/ﬂox prostate ducts showed about 59% (Pb0.01) lower content of
p63+epitheliumwhen compared to control tissues (Figs. 8A, B, and E). At
P7, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox epithelium contained only 28% (Pb0.01) of
the normal p63+ cells (Figs. 8C–E). Further, we found that Nkx3.1Cre/+;
RBP-Jﬂox/ﬂox prostates, analyzed fromP1 to P14 consistently showed about
14% (Pb0.01)morePTEN+cells in theprostate epithelium, andabout32%
(Pb0.01) more PTEN+ cells in the periductal mesenchyme (Figs. 8F–H,
and data not shown). Themajor function of PTEN is to negatively regulate
the PI3K/Akt cell survival pathway (Salmena et al., 2008). Thus, the
increase in PTEN in the Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostate epithelium is
likely to account for the decreased survival and proliferation of the p63+
cells. Further examination of Nkx3.1Cre/+;RBP-Jﬂox/ﬂox periductal stroma at
P7 showed signiﬁcantly lower content of α-sma+ cells, as well as
discontinuous smoothmuscle envelopes in the distal regions of the gland
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levels of PTEN are present only in vimentin+ cells, namely, in
vimentin+α-sma− ﬁbrobasts and vimentin+α-sma+ myoﬁbroblasts
(Fig. 9). In contrast, vimentin−α-sma+ myoblasts and myocytes were
negative for PTEN (Figs. 9B and D). Thus, loss of RBP-J, and a resulting
increase in PTEN in theprostate stroma result in a shift fromthemyoblast
to ﬁbroblast lineage.
Loss of Notch/RBP-J function results in abnormal organization of the
ductal epithelium and smooth muscle
We next examined young adult Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostates
at P21 and P28 for abnormalities in tissue organization and cellular
composition (Figs. 10 and 11). Histological analysis of Nkx3.1Cre/+;
RBP-Jﬂox/ﬂox prostate sections at P28 (Fig. 10B) revealed distended
ductal lumens and abnormally thin epithelium in 80% (Pb0.01) of
ventral prostate ducts, and in 67% (Pb0.01) of the lateral ducts. In
addition, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox ventral and lateral prostate ducts
showed thin and discontinuous smooth muscle envelopes (Fig. 10B,
arrowhead; and Fig. 11H). Analysis of epithelial differentiation,
conducted at P21, showed that Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostate
ducts failed to compartmentalize the CK8+, basal, and CK14+,
luminal, epithelium in all prostate lobes (Figs. 11A–C, E–G, anterior
prostate is shown). Nkx3.1Cre/+;RBP-Jﬂox/ﬂox prostates also showed
signiﬁcantly reduced epithelial secretions in all prostate lobes (Fig. 10,
and data not shown). These ﬁndings are consistent with defects in
epithelial differentiation in cNotch1 null prostates (Wang et al., 2006).
In thenormal differentiatedprostate ducts, CK14 is expressed in thebasal
epithelium, and is absent from the luminal compartment (Figs. 11B and
C). In turn, CK8 is expressed exclusively in the luminal epithelium
(Figs. 11A and C). In contrast, in the Nkx3.1Cre/+;RBP-Jﬂox/ﬂox ducts most
CK8+ cells co-express CK14 (Figs. 11E–G). In wild-type prostate ducts,
CK14+basal cells have a characteristic elongatedmorphology and attach
along the basal membrane (Fig. 11B). In contrast,Nkx3.1Cre/+;RBP-Jﬂox/ﬂox
ducts contained large CK14+ cells that extended towards the lumen
(Fig. 11F). Thus, loss of Notch/RBP-J function in the developing prostate
resulted in defects in speciﬁcation of the basal and luminal prostate
epithelium, and the smooth muscle cells.
Discussion
We and other laboratories have shown the importance of the
Notch cell fate selection system in regulating prostate growth,
regeneration and epithelial differentiation (Grishina et al., 2005;
Wang et al., 2004, 2006). Notch signaling is also required for the
maintenance of epithelial progenitors in the pancreas, intestine and
mammary gland (Buono et al., 2006; Fre et al., 2005; Murtaugh et al.,
2003; Stanger et al., 2005). In this study, we employed conditional
murine models to systematically investigate the role of Notch
signaling in development of the prostate epithelium and stroma.
Our analysis of gain and loss of Notch function indicates that during
normal development, Notch signaling inhibits accumulation of the
tumor suppressor PTEN in the UGS and prostate epithelium, and in the
adjacent stroma. Notch-dependent inhibition of PTEN has been
reported to regulate cell survival and proliferation in T-cell leukemias
(Palomero et al., 2007). In contrast, Notch has been suggested to
upregulate PTEN in Du145 and 22Rv1 prostate cancer cell lines
(Whelan et al., 2009). Our studies in conditional murine models
strongly indicate that during normal prostate development Notch
signaling inhibits accumulation of PTEN, and supports maintenance of
the patterned progenitor cells in the epithelial and smooth muscle
compartments. We show that gain of Notch function in the embryonic
prostates results in a signiﬁcant decrease in the levels of PTEN, and
increase in the active phosphorylated form of Akt, and its target, Bcl2,
both in the prostate epithelium andmesenchyme. Consistent with the
effects of gain of Notch function, loss of Notch/RBP-J resulted inupregulation of PTEN, and decreased rates of cell division and survival
in the prostate epithelium and smooth muscle.
Next, our ﬁndings strongly indicate a positive role for Notch sig-
naling in maintenance of the p63+ basal progenitors (Kurita et al.,
2004; Robinson et al., 1998; Signoretti et al., 2005; Wang et al., 2001).
Gain of Notch function resulted in formation and maintenance of a
50% larger population of basal progenitors in the urogenital sinus.
Gain of Notch function also resulted in a higher rates of epithelial cell
divisions throughout development, and an increased mass of basal
and luminal epithelial cells in the adult prostates. This resulted in the
early onset of prostate hyperplasia at three months of age
manifested in increased mass of the basal and luminal epithelium.
Interestingly, our results indicate that gain of Notch signaling does
not prevent speciﬁcation of the luminal epithelium. Gain of Notch
activity also resulted in hyperproliferation of the patterned smooth
muscle progenitor cells, the α-actin-positive myoblasts. As a result,
PBCre4/+;RosaN1IC/+ prostates form abnormally thick smooth muscle
envelopes and develop ﬁbromuscular nodules in the glandular
stroma. These epithelial and stromal pathologies are consistent with
benign prostate hyperplasia in men (Lee and Peehl, 2004), and in
murine models (Kim et al., 2002).
Consistent with the effects of gain of Notch function, loss of Notch/
RBP-J resulted in upregulation of PTEN, decreased rates of cell division
and survival in the prostate epithelium, and a rapid loss of basal
prostate progenitors, postnatally. Loss of Notch function also resulted
in defects in differentiation of the basal and luminal epithelium.
Previous studies employed pharmacological γ-secretase inhibitors,
and performed a conditional deletion of the Notch1 receptor in the
postnatal prostate, to show the importance of Notch signaling for
compartmentalization and secretory differentiation of the prostate
epithelium (Wang et al., 2006). Our studies show that loss of Notch
function resulted in a signiﬁcant decrease in cell survival and
proliferation, as well as severe defects in epithelial differentiation in
the embryonic, postnatal and adult prostate. Embryonic and newborn
UGS epithelium is normally multilayered and pseudostratiﬁed. In
contrast, loss of Notch signalingmanifested in a severe reduction of the
UGS epithelium to a single layer of cuboidal cells at the basal
membrane. Defects in epithelial differentiation also manifested in
the prostate ducts. Normal differentiated prostate ducts contain small
elongated basal cells stretched along the lamina, and a single layer of
luminal epithelium. Loss of Notch signaling resulted in severe defects
in compartmentalization of the basal and luminal epithelial layers. As
result, Nkx3.1Cre/+;RBP-Jﬂox/ﬂox ducts contained abnormally large
CK14+ basal cells which extended into the luminal compartment,
and co-expressed the luminal marker, CK8. In summary, our studies
show that Notch signaling controls survival and proliferation of the
pluripotent basal progenitors, and that precise level of Notch signaling
is necessary for speciﬁcation of the basal and luminal lineages.
Our studies also strongly indicate the importance of Notch
signaling for maintenance and differentiation of smooth muscle
progenitors. Gain of Notch function resulted in increased proliferation
of myoblast progenitors, a delay in terminal differentiation, and
formation of an additional 3rd layer of smooth muscle in the adult
gland. Persistent Notch signaling also caused a delay in condensation
of smooth muscle. At P14, adolescent prostates were surrounded by
thick but loosely packed smooth muscle envelopes, which retained
partially-differentiatedmyoblasts. Consistently, loss of Notch function
manifested in loss of myoblasts, and abnormally thin and discontin-
uous smooth muscle envelopes. Interestingly, we found that loss of
Notch function and increase in PTEN+ cells in the periductal
mesenchyme favored the PTEN+, vimentin+ ﬁbroblast lineage over
the PTEN−vimentin−α-sma+ myoblasts and myocytes (Hayward et
al., 1996). This is a strong evidence thatNotch signaling is necessary for
maintenance and differentiation of the smooth muscle lineage. The
role for Notch in differentiation of the smooth muscle is a relatively
novel concept. However, recent report pointed to the signiﬁcance of
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stroma (Orr et al., 2009). Other studies implicated Notch1 in
differentiation and proliferation of the arterial smooth muscle (Feng
et al., 2010; Tang et al., 2010; Morrow et al., 2010). In addition, ectopic
Notch1 signaling has been implicated in the pathological differenti-
ation of myoﬁbroblasts in pulmonary ﬁbrosis (Liu et al., 2009), and in
osteogenic mineralization of vascular smooth muscle in arteosclerotic
plaques (Shimizu et al., 2009).
Our analysis of the Nkx3.1Cre;Rosa26 reporter system revealed that
Nkx3.1Cre drives Cre expression in the prostate epithelium and smooth
muscle compartments. This suggests that the Nkx3.1 prostate-speciﬁc
homeobox factor (Bhatia-Gaur et al., 1999) functions to pattern both
prostate-speciﬁc epithelium and adjacent mesenchyme. In addition,
we show that both prostate-speciﬁc drivers used in this study, the
Nkx3.1Cre and PBCre4, target Cre expression to the same domains in the
postnatal prostate epithelium and smooth muscle. In further support,
we experimentally conﬁrmed the increase Notch1 signaling in the
embryonic Nkx3.1Cre;RosaN1IC urogenital mesenchyme, and in PBCre4;
RosaN1IC smooth muscle. Thus, we provide evidence that in our
systems, Notch signaling is modulated cell-autonomously in the
epithelium and stroma. Yet, considering the importance of signaling
interactions between the epithelium and mesenchyme for prostate
development and homeostasis, it is necessary to evaluate other
signalingpathwayswhichmay contribute to the observedphenotypes.
For instance, signaling by the epithelial Sonic hedgehog (Shh)
(Podlasek et al., 1999), Bonemorphogenetic proteins 4 and 7 (Grishina
et al., 2005; Lammet al., 2001) andWntmolecules (Huang et al., 2009;
Ontiveros et al., 2008; Yu et al., 2009) can affect differentiation of the
myoblast progenitors and formation of the periductal smooth muscle
(Perez et al., 2011; Shaw et al., 2006). Our unpublished studies in
embryonic Nkx3.1Cre/+;RosaN1IC/+ and Nkx3.1Cre/+;RBP-Jﬂox/ﬂox pros-
tates indicate that Notch signaling does not affect expression of the
Shh ligand. Although, we did not examine expression of the Shh
reporters and mediators, signaling by the Bmp and Wnt ligands have
been shown to inhibit PTEN in the normal and cancerous prostate
epithelium (Jerde et al., 2011; Ohigashi et al., 2005). Our unpublished
studies indicate that gain and loss of Notch signaling in the embryonic
prostates do not affect the Bmp/phospho-Smad1/5/8 pathway.
However, our previous studies show that Notch and Wnt pathways
function in the same cell populations in the prostate epithelium and in
the adjacent mesenchyme (Grishina et al., 2005; Wu et al., 2011). We
also found that gain of Notch function the embryonic prostates
resulted in upregulation of Lef1, a mediator and reporter in the
canonical Wnt pathway (Wu et al., 2011, and our unpublished data).
Other reports conﬁrm the complex interactions between the Notch
and Wnt pathways in maintenance of the progenitor cells and their
niche (Buske et al., 2011; Radtke et al., 2006; Shahi et al., 2011). Thus,
further studies should clarify the roles and interactions betweenNotch
andWnt pathways in maintenance and differentiation of the prostate
progenitor cells in the epithelial and stromal compartments.
In the last decade, studies in multiple species and organs systems
pointed to the importance of the Notch cell fate selection system in
maintenance and proliferation of pluripotent progenitors, and the
importance of timely inhibition of Notch signaling for differentiation of
the secretory andneural lineages. Our analysis of the effects of gain and
loss of Notch signaling during prostate development demonstrates the
importance of ﬁne regulation of Notch signaling for proper develop-
ment of the prostate epithelium and smoothmuscle. The peculiarity of
prostate homeostasis is that prostate retains a high number of
progenitor/stem cells in the adult tissue which allows for prostate
regeneration, and also makes the gland vulnerable to the hormonal
and developmental signals, such as by steroid hormones, and Notch
and Wnt ligands. Importantly, our studies demonstrate that both loss
and gain of Notch function have signiﬁcant consequences for prostate
differentiation and tissue integrity, and can lead to abnormal tissue
homeostasis and predisposition to disease in the adult organ.Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.05.659.
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